When assessing fold induction (FI) of CD19+ B-cells relative to ex vivo levels, stimulation with condition II yielded substantially higher FI values in both HCs (FI = 7) and CVID patients (FI = 3.5). This evidence concerns the gene CD19 and common variable immunodeficiency.